Cancer doctors pledge to widen access to pain relief in developing countriesBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4645 (Published 26 August 2010) Cite this as: BMJ 2010;341:c4645
- Tatum Anderson
Cancer advocates plan to broker deals with drug companies to get cheaper, more plentiful supplies of pain relief drugs to patients in developing countries using models pioneered in the field of HIV/AIDS.
The plans form part of the Global Access to Pain Relief Initiative (GAPRI), a strategy launched at the World Cancer Congress, in China on 19 August. Led by the International Union Against Cancer (UICC), which represents 350 cancer charities including Cancer Research UK, GAPRI has the backing of organisations including the World Health Organization, the American Cancer Society, and the World Economic Forum.
GAPRI will tackle the lack of access to strong opioid based pain relief. Today, a few rich nations, including the UK and US, consume …